Vanda Pharmaceuticals (NASDAQ:VNDA) said the US Court of Federal Claims in Washington, D.C., is allowing the company to proceed with its lawsuit against the FDA over the handling of certain ...
Vanda Pharmaceuticals and the FDA have agreed to lay down their swords, squashing years of legal disputes with an agreement that will see regulatory action on much of Vanda’s grievances. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback